Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action.

Saved in:
Bibliographic Details
Title: Enabling CAR T-cell therapies for HIV-positive lymphoma patients - A call for action.
Authors: Hattenhauer ST; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Mispelbaum R; Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany., Hentrich M; Department of Internal Medicine III, Red Cross Hospital Munich, Munich, Germany., Boesecke C; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), partner-site Cologne-Bonn, Bonn, Germany., Monin MB; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; German Centre for Infection Research (DZIF), partner-site Cologne-Bonn, Bonn, Germany.
Source: HIV medicine [HIV Med] 2023 Sep; Vol. 24 (9), pp. 957-964. Date of Electronic Publication: 2023 Jun 15.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293 (Electronic) Linking ISSN: 14642662 NLM ISO Abbreviation: HIV Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1468-1293
DOI:10.1111/hiv.13514